BeStock  
Stocks › Medical Devices › BBNX

Beta Bionics BBNX

US equityMarket cap rank #3400Medical Devices
$18.08 −$0.55 (-2.95%)
Pre-market · Oct 8, 8:10 am ET · After hours $18.08 0.00%
Open$18.91
Prev close$18.63
Day range$17.93 – $19.11
Volume1.53M
Market cap$813.41M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$32.01M+37.8% YoY
Operating profit-$25.58M-28.7% YoY
Net profit-$23.40M-38.7% YoY
Diluted EPS-$0.53-35.9% YoY
Free cash flow-$15.66M-1.9% YoY
Operating cash flow-$14.62M

Revenue, last 8 quarters

$16.7MSep '24$20.4MDec '24$17.6MMar '25$23.2MJun '25$27.3MSep '25$32.1MDec '25$27.6MMar '26$32.0MJun '26

Net profit, last 8 quarters

$-9.7MSep '24$-18.1MDec '24$-28.7MMar '25$-16.9MJun '25$-14.2MSep '25$-13.5MDec '25$-21.9MMar '26$-23.4MJun '26

Diluted EPS by quarter

-0.23Sep '24-0.42Dec '24-0.93Mar '25-0.39Jun '25-0.33Sep '25-0.30Dec '25-0.49Mar '26-0.53Jun '26

Free cash flow by quarter

$-11.5MSep '24$-14.8MDec '24$-20.3MMar '25$-15.4MJun '25$-10.0MSep '25$-10.5MDec '25$-25.2MMar '26$-15.7MJun '26

Annual revenue

$179.0KFY22$12.0MFY23$65.1MFY24$100.3MFY25

Profitability & balance sheet

Gross margin58.3%
Operating margin-69.8%
Net margin-61.3%
Return on equity-26.2%
Return on assets-23.5%
Return on invested capital-29.1%
Current ratio8.88
Liabilities / assets12.3%
Cash & investments$180.49M
Total debt$4.92M
Net cash (debt)$175.57M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Single-use products$19.14M 59.8%
  • iLet$12.87M 40.2%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $32.01M $27.63M $100.25M $32.12M $27.25M
Total Operating Revenue $32.01M $27.63M $100.25M $32.12M $27.25M
Cost of Revenue $13.11M $11.19M $44.71M $13.18M $12.13M
Gross Profit $18.90M $16.44M $55.54M $18.94M $15.12M
Operating Expense $44.48M $40.71M $127.22M $35.07M $32.16M
Selling and Admin Expenses $34.24M $30.35M $92.43M $24.94M $23.97M
-Selling & Marketing Expense $24.64M $20.74M $61.40M $16.33M $16.05M
-General & Admin Expense $9.60M $9.62M $31.03M $8.60M $7.92M
Research & Development $10.24M $10.36M $34.79M $10.13M $8.20M
Operating Profit -$25.58M -$24.27M -$71.68M -$16.12M -$17.04M
Net Non-Operating Interest Income (Expense) $2.18M $2.38M $10.93M $2.66M $2.83M
Non-Operating Interest Income $2.18M $2.38M $10.93M $2.66M $2.83M
Other Income (Expense) -$2,000.00 – -$12.45M -$1,000.00 –
Other Non-Operating Income (Expenses) -$2,000.00 – -$1,000.00 – –
Pretax Profit -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Net Profit -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Profit from Continuing Operations -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Net Income to Parent Company -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Net Income to Common Stockholders -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Basic EPS -$0.53 -$0.49 -$1.81 -$0.30 -$0.33
Diluted EPS -$0.53 -$0.49 -$1.81 -$0.30 -$0.33
Gain on Sale of Security – – -$12.45M $0.00 –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $292.39M $304.42M $328.74M $328.74M $330.05M
Total Current Assets $231.03M $247.99M $267.91M $267.91M $270.03M
Cash and Cash Equivalents & Short-Term Investments $180.49M $199.52M $219.13M $219.13M $228.69M
-Cash and Cash Equivalents $44.32M $30.21M $31.58M $31.58M $38.49M
-Short Term Investments $136.17M $169.31M $187.55M $187.55M $190.20M
Receivables $20.25M $18.14M $19.89M $19.89M $14.25M
-Accounts Receivable $18.05M $15.75M $17.12M $17.12M $11.54M
-Accrued Interest Receivable $1.91M $2.14M $2.51M $2.51M $2.72M
-Taxes Receivable $293,000.00 $251,000.00 $265,000.00 $265,000.00 –
Prepaid Assets $6.28M $6.50M $7.06M $7.06M $6.45M
Inventory $23.92M $23.73M $21.72M $21.72M $20.37M
Restricted Cash $100,000.00 $100,000.00 $100,000.00 $100,000.00 –
Total Non-Current Assets $61.35M $56.43M $60.84M $60.84M $60.02M
Net PPE $16.56M $16.39M $15.23M $15.23M $14.41M
-Gross PPE $23.61M $22.73M $20.98M $20.98M $20.70M
-Accumulated Depreciation -$7.05M -$6.34M -$5.76M -$5.76M -$6.29M
Investments and Advances $44.65M $39.87M $45.43M $45.43M $45.33M
-Available for Sale Securities $44.65M $39.87M $45.43M $45.43M –
Other Non-Current Assets $141,000.00 $181,000.00 $180,000.00 $180,000.00 $283,000.00
Total Liabilities $36.02M $33.17M $41.13M $41.13M $35.29M
Total Current Liabilities $26.02M $23.19M $30.92M $30.92M $25.39M
Payables $5.35M $2.32M $5.00M $5.00M $4.46M
-Accounts Payable $5.35M $2.32M $5.00M $5.00M $4.46M
Current Accrued Expenses $5.03M $6.11M $7.84M $7.84M $4.88M
Short-Term Debt and Capital Lease Obligation $1.59M $1.84M $1.94M $1.94M $1.98M
-Current Capital Lease Obligation $1.59M $1.84M $1.94M $1.94M $1.98M
Current Provisions $1.66M $1.61M $1.61M $1.61M $1.35M
Current Deferred Liabilities $1.88M $1.71M $1.56M $1.56M $1.34M
Other Current Liabilities $554,000.00 $623,000.00 $328,000.00 $328,000.00 $369,000.00
Total Non-Current Liabilities $10.00M $9.98M $10.21M $10.21M $9.90M
Long Term Debt and Capital Lease Obligation $4.92M $5.07M $5.37M $5.37M $5.71M
-Long Term Capital Lease Obligation $4.92M $5.07M $5.37M $5.37M $5.71M
Non-Current Deferred Liabilities $3.45M $3.35M $3.30M $3.30M $2.99M
Convertible preferred securities $0.00 – $0.00 $0.00 $0.00
Other Non-Current Liabilities $1.63M $1.56M $1.55M $1.55M $1.21M
Total Equity $256.37M $271.25M $287.61M $287.61M $294.76M
Stockholders' Equity $256.37M $271.25M $287.61M $287.61M $294.76M
Capital Stock $5,000.00 $5,000.00 $4,000.00 $4,000.00 $4,000.00
-Common Stock $5,000.00 $5,000.00 $4,000.00 $4,000.00 $4,000.00
Additional Paid-In Capital $671.99M $663.17M $657.14M $657.14M $650.87M
Retained Earnings -$415.24M -$391.83M -$369.94M -$369.94M -$356.47M
Gains/Losses Not Affecting Retained Earnings -$390,000.00 -$96,000.00 $403,000.00 $403,000.00 $354,000.00
Non-Current Deferred Assets – – $0.00 $0.00 $0.00
Derivative Product Liabilities – – $0.00 $0.00 $0.00
-Preferred Stock – – $0.00 $0.00 $0.00
Other Current Assets – – – – $265,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$14.62M -$23.83M -$50.93M -$8.63M -$8.73M
Net cash flow from continuing operations -$14.62M -$23.83M -$50.93M -$8.63M -$8.73M
Net Income from Continuing Operations -$23.40M -$21.90M -$73.20M -$13.47M -$14.21M
Depreciation & Depletion & Amortization $1.12M $987,000.00 $2.88M $935,000.00 $683,000.00
Change in Working Capital $513,000.00 -$8.21M -$8.99M -$1.34M $317,000.00
-Change in Receivables -$2.32M $1.37M -$5.16M -$5.60M -$168,000.00
-Change in Inventory -$214,000.00 -$1.80M -$9.88M -$2.20M -$3.33M
-Change in Prepaid Assets $415,000.00 $951,000.00 -$5.81M -$413,000.00 -$1.79M
-Change in Payables and Accrued Expense $2.64M -$8.55M $9.52M $6.39M $5.22M
-Change in Other Current Assets $40,000.00 -$1,000.00 -$30,000.00 $3,000.00 -$39,000.00
-Change in Other Current Liabilities -$329,000.00 -$380,000.00 $311,000.00 -$42,000.00 -$91,000.00
-Change In Other Working Capital $280,000.00 $201,000.00 $2.06M $526,000.00 $517,000.00
Net cash flow from investing $26.93M $21.84M -$162.81M $658,000.00 $9.49M
Net Cash Flow from Continuing Investing Activities $26.93M $21.84M -$162.81M $658,000.00 $9.49M
Net PPE Purchase and Sale -$1.04M -$1.38M -$5.30M -$1.90M -$1.28M
Net Investment Purchase and Sale $27.97M $23.22M -$157.51M $2.56M $10.77M
Financing Cash Flow $1.80M $623,000.00 $214.87M $1.06M $2.65M
Net Cash Flow from Continuing Financing Activities $1.80M $623,000.00 $214.87M $1.06M $2.65M
Net Common Stock Issuance $0.00 $0.00 $210.12M -$904,000.00 $0.00
Proceeds from Stock Option Exercised $1.80M $623,000.00 $4.76M $1.96M $2.65M
Ending Cash Balance $44.42M $30.31M $31.68M $31.68M $38.59M
Net Change in Cash $14.11M -$1.37M $1.14M -$6.91M $3.41M
Beginning Cash Balance $30.31M $31.68M $30.53M $38.59M $35.18M
Free Cash Flow -$15.66M -$25.21M -$56.22M -$10.53M -$10.01M
Other Non-Cash Items – $86,000.00 -$2.05M -$25,000.00 –
Gain/Loss from Continuing Operations – – $12.48M $31,000.00 $0.00
Net Preferred Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on BBNX.

Leave a comment

Scroll to Top